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Abstract
Healthcare-associated infections (HAIs) are causes of mortality and morbidity worldwide. The prevalence of bacterial
resistance to common antibiotics has increased in recent years, highlighting the need to develop novel alternatives for
controlling these pathogens. Pitviper venoms are composed of a multifaceted mixture of peptides, proteins and inorganic
components. L-amino oxidase (LAO) is a multifunctional enzyme that is able to develop different activities including
antibacterial activity. In this study a novel LAO from Bothrops mattogrosensis (BmLAO) was isolated and biochemically
characterized. Partial enzyme sequence showed full identity to Bothrops pauloensis LAO. Moreover, LAO here isolated
showed remarkable antibacterial activity against Gram-positive and -negative bacteria, clearly suggesting a secondary
protective function. Otherwise, no cytotoxic activities against macrophages and erythrocytes were observed. Finally, some
LAO fragments (BmLAO-f1, BmLAO-f2 and BmLAO-f3) were synthesized and further evaluated, also showing enhanced
antimicrobial activity. Peptide fragments, which are the key residues involved in antimicrobial activity, were also structurally
studied by using theoretical models. The fragments reported here may be promising candidates in the rational design of
new antibiotics that could be used to control resistant microorganisms.
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Introduction
Healthcare-associated infections (HAIs) are causes of mortality
and morbidity worldwide. It is estimated that the incidence of
HAIs is around 5–10% in developed countries, with a frequency
exceeding 25% in developing nations. HAIs can be caused by a
number of micro-organisms such as bacteria, fungi and viruses [1].
Nevertheless, the pathogens involved in infectious processes consist
mainly of constitutive bacteria from normal human microbiota.
These bacteria are innocuous in healthy individuals but are able to
cause severe and dangerous infections, mainly in immunocom-
promised individuals [2]. Moreover, the prevalence of bacterial
resistance to common antibiotics has increased in recent years,
emphasising the need to develop novel alternatives for controlling
these pathogens [2].
Indeed, the pursuit of unusual substances from natural sources
has been extensive. Animal venoms are considered important
sources of novel therapeutic agents due to their unusual and
complex protein composition. Pitviper venoms are composed of a
multifaceted mixture of peptides, proteins and inorganic compo-
nents [3,4]. Among venomous proteins are included phospholipase
A2, desintegrins, metalo- and serine proteinases, nerve growth
factors (NGFs), L-amino acid oxidases (LAO) and severalothers [3].
LAO is a classical flavoprotein that catalyzes the oxidative
deamination of L-amino acids, converting them into keto acids,
ammonia and hydrogen peroxide (H2O2) [5]. Furthermore, LAO is
a multifunctional enzyme that is able to carry out different activities
such as decreasing platelet aggregation [6], stimulating edema
formation [7], controlling tumorous cells [8] or acting as deleterious
factors toward multiple pathogens such as bacteria, protozoa and
viruses [3,9–11]. Moreover, multifunctional LAOs could act as host
defence for other organisms, since they normally occur in a wide
variety of animal fluids such as milk [12] and epidermal mucus [10].
Knowledge of the defensive potential of L-amino-oxidases has
recentlyimprovedsignificantly,includingthepossiblemechanism of
action. Yang et al. [13], working with a fungal LAO, demonstrated
that the enhancing of H2O2 related to enzyme activity could lead to
cell damage, and also lipid peroxidation and DNA strand breakage,
causing reduction in bacterial development. Similar antibacterial
activity was obtained with LAO isolated from rabbitfish (Siganus
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the host’s non-specific immune defense mechanism to control
microorganisms [14]. Moreover, this antimicrobial activity was also
reported in LAOs isolated from snake venoms. De Melo Alves et al.
[15] showed that LAO isolated from Bothrops atrox venom displays
remarkable bactericidal activity against both Gram-positive and
Gram-negative bacteria in addition to antiprotozoal activity.
Similar data were obtained with LAO isolated from venom of
Ophiophagus hannah [16] in which higher antimicrobial activities with
lower MICs were observed.
For this reason, the LAO group has been focused as a possible
source of antimicrobial toolsfor biotechnological and pharmaceutical
purposes.In summary, this study presents a novel LAO, isolated from
B. mattogrosensis (BmLAO) venom. In addition to enzymatic activity,
the LAO was evaluated, taking into account its antimicrobial
properties, which showed clear activity against Gram-positive and
-negative bacteria, clearly suggesting a secondary and promiscuous
protective function. Otherwise, no cytotoxic activity against macro-
phages and erythrocytes was observed. In order to make the use of
this protein possible for biotechnological purposes, protein was
structurally evaluated and further fragmented in order to reduce the
size, maintaining the antimicrobial activity. Complete LAO protein
was fragmented according to exposed charges and hydrophobic
moment, since most antimicrobial peptides with activity against
Gram-positive and –negative bacteria are cationic and show at least
one hydrophobic face. LAO fragments yielded were synthesized and
were functional, and in silico structural analyses produced the first
report of LAO fragments with antimicrobial activity.
Materials and Methods
Venom extraction
Crude Bothropoides mattogrosensis venom was collected from 16
adult specimens from the serpentarium at the Universidade
Cato ´lica Dom Bosco by direct pressure of snake venom glands.
This study was approved by the Animal Use Committee (CEUA)
at the Institute of Biological Sciences, University of Brasilia. The
venom was pooled, lyophilized and stored at 220uC. The total
protein was quantified using the Bradford assay [17].
L-amino acid oxidase isolation
Firstly, 30 mg.mL
21 of freeze-dried B. mattogrosensis crude venom
was re-suspended in 50 mM Tris-HCl buffer pH 7.5 and filtered
through 0.22 mm nylon membranes. Extract was applied onto a
Sephacryl S-100 gel filtration chromatograph (Pharmacia, Sweden
– 25–75 mm, 600 mm635 mm) previously equilibrated with the
same buffer. The crude venom was eluted with 50 mM Tris-HCl
buffer pH 7.5 at a flow rate of 1.8 mL.min
21. Fractions of 3.0 ml
were collected and monitored at 280 nm. The fractions were
dialyzed with membrane cut-off of 3.5 kDa (Spectrum Laborato-
ries, USA) and further lyophilized. The active fractions were
quantified using the Bradford assay [17] and monitored through
bioassays against Gram-positive and -negative bacteria as described
below. Reversed-phase high performance liquid chromatography
(RP-HPLC) was performed by using a semi-preparative RP-HPLC
C18 (Vydac, USA - 5 mm, 250 mm610 mm). Retained peptides
were eluted with a linear gradient of 5 to 95% acetonitrile/TFA
0.1% (v/v). Chromatography was run for 60 min at a flow rate of
2.5 mL.min
21. The experiment was monitored at 280 nm.
Fractions were manually collected and lyophilized.
Mass spectrometry and de novo sequencing
Determination of molecular mass peptides was performed by
using an UltraFlex II MALDI-ToF/ToF Mass Spectrometer
(Bruker Daltonics, USA). The fractions with activity were dissolved
in a-cyano-4-hydroxycinnamic acid matrix solution (1:3, v/v),
spotted onto a MALDI target massive plate and dried at room
temperature for 15 min. The peptides’ monoisotopic mass were
obtained in reflector mode with external calibration, using the
Peptide Calibration Standard for Mass Spectrometry calibration
mixture (up to 4,000 Da mass range, Bruker Daltonics). MS/MS
spectra were obtained by LIFT/CID fragmentation. Primary
structures of the peptides were manually interpreted, and isomeric
and isobaric residues were assigned based on the high-energy
fragmentation ions according to [18]. FlexAnalysis 2.4 (Bruker
Daltonics) and PepSeq (MicroMass) software were used to
interpret mass spectra.
Sequence analysis
The search for similar sequences was performed by using Blastp
program [19] using non-redundant protein database. ClustalW tool
[20] was used to calculate the identity and similarity scores among
thesequencedpeptides,andtheprimarystructureofLAOsequences
with three-dimensional structures was experimentally resolved.
Measurement of LAO activity
Assessment of LAO activity was conducted in 96-well micro-
plates, with 10 mL of enzyme solution per well, and 90 mL
21 of
substrate was added to initiate the reaction. The reaction medium
consisted of a total volume of 100 mL containing 10 mM Tris-HCl
buffer pH 7.4, 250 mM L-leucine, 2 mM o-phenylenediamine
(OPD), 0.81 U.mL-1 of hydrogen peroxide (H2O2). After incuba-
tion at 37uC for 20 min, the reaction was finished by adding 50 mL
of 2M H2SO4. The absorbance of the reaction mixture was
measured at 490 nm, and enzyme activity was expressed as the
increase in absorbance after the incubation time [21].
Solid-phase peptide synthesis
After LAO sequencing, some internal peptides were selected for
chemical synthesis. These peptides, obtained by MALDI ToF/ToF
analysis, were selected on the basis of 20 to 30% of theoretical
hydrophobicity and charges from 0 to +3 in pH 7.0. Parameters
were calculated by using Protein Calculator v3.3 server (http://
www.scripps.edu/,cdputnam/protcalc.html). Selected peptides
were synthesized by stepwise solid-phase with the N-9-fluorenyl-
methyloxycarbonyl (Fmoc) strategy [22] using a Rink amide resin
(0.4 mmol.g
21). Side chain protecting groups (t-butyl for threonine
and (triphenyl)methyl for histidine) were added. Couplings were
performed with 1,3-diisopropylcarbodiimide/1-hydroxybenzotria-
zole in N,N-dimethylformamide (DMF) for 90 min. Deprotections
(15 min, twice) were conducted by piperidine:DMF solution (1:4;
v:v). Cleavage from the resin and final deprotection were performed
with TFA/water/1,2-ethanedithiol (EDT)/triisopropylsilane (TIS),
94.0/2.5/2.5/1.0, by volume) at room temperature for 90 min.
After precipitating the product of cleavage with cold diisopropyl
ether the crude peptide was extracted with distilled water and
acetonitrile at 50% by volume. The extracted peptide was freeze-
dried and further lyophilized for purification. The synthetic peptide
concentrations for all experiments in vitro were measured as
described by Murphy and Kies [23] using ABS215 and ABS225
nm. No peptide presented tryptophan in its sequences.
Determination of minimal inhibitory concentration (MIC)
The minimal inhibitory concentration (MIC) was determined
using a standardized dilution method according to NCSLA
guidelines [24]. Overnight colonies of Bacillus subtilis (ATCC
6633), Enterococcus faecalis (ATCC 12953), Staphylococcus aureus
Antimicrobial LAO from Pitviper Venom
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(ATCC8739), Klebsiella pneumonia (ATCC13885), Proteus mirabilis
(ATCC25933), Pseudomonas aeruginosa ATCC 15442 and Salmonella
typhimurium (ATCC14028) were suspended to a turbidity of 0.5
units and further diluted in Mueller-Hinton broth (MH) (Himedia
- India). For determination of MIC, protein was used in graded
concentrations (0, 1, 2, 4, 8, 16, 32, 64, 128, 256 and
512 mg.mL
21) from a stock solution. Ten microliters of each
concentration was added to each corresponding well of a 96-well
plate (TPP, Switzerland) and 1610
5 bacteria in the volume of
90 mL. The plate was incubated at 37uC for 12 h.
Hemolysis assay
Human heparine-blood was obtained from the Universidade
Cato ´lica de Brasilia cell collection. Collection was obtained with
written informed consent. Heparine blood cells were centrifuged at
800 g for 10 min. The erythrocytes were washed three times and
re-suspended in 0.1% PBS, pH 7.4. The 10% erythrocyte
suspension (v/v) was further incubated for 1 h at 37uC in the
presence of fractions F-44, F-51, F-68, BmLAO (0–512 mg.mL
21)
and fragments BmLAO-f1, BmLAO-f2 and BmLAO-f3 at different
concentrations (0–340 mM). The positive control was 0.1% triton
X-100 (Sigma-Aldrich, USA). The samples were then centrifuged
at 800 g for 10 min. The optical density at 540 nm of the
supernatant was measured. The relative optical density compared
to that of the suspension treated with 0.1% triton X-100 defined
hemolysis percent [25].
Cell cytotoxicity
Sterile filtered MTT (3-(4,5-dimethylthiazolyl)-2,5-diphenyl-tet-
razoliumbromide; Sigma-Aldrich, USA) solution (5 mg.mL
21 in
PBS) was dark stored at 220uC. RAW 264.7 murine macrophage-
like cells, 1610
5 cells/well was seeded in 96 well plates (TPP,
Switzerland), in supplemented DMEM medium (4 mM glutamine,
10% FCS and 100 units.ml
21 penicillin/streptomycin) containing
multiple treatments. Treatments consisted of fractions F-44, F-51,
F-68, BmLAO (0–512 mg.mL
21) and fragments BmLAO-f1,
BmLAO-f2 and BmLAO-f3 at different concentrations (0–
500 mM). After overnight incubation, 60% of medium was then
removed, and 10 ml of the MTT solution was added to each well;
the plates were then incubated for 4 h in the presence of 5% CO2 at
37uC. The blue formazan product generated was dissolved by the
addition of 100 ml of 100% DMSO (Mallinckrodt Chemical) per
well. The plates were then gently swirled for 5 min at room
temperature in order to dissolve the precipitate. The absorbance
was monitored at 575 nm in a Biotek Powerwave HT microplate
spectrophotometer (Bio-Tek Instruments, USA) [26].
In silico molecular modelling
The LAO from Vipera ammodytes ammodytes (PDB 3kve), resolved
through X-ray diffraction presenting a crystal with resolution of
2.57 A ˚ [27], was used as template for molecular model
construction. The fragments showed 100% of identity with
acquired sequences. Two hundred theoretical three-dimensional
structures for each peptide were constructed using the previously
described Modeller v.9.8 [28] as a template. The final models were
evaluated for their geometric, stereochemical, and energy
distributions by using PROCHECK [29]. In addition, RMSD
was calculated by overlap of Ca traces and backbones onto the
template structure through the program 3DSS [30]. The
electrostatic surfaces were calculated with the ABPS tool [31].
The protein structures were visualized and analyzed on Swiss PDB
viewer v.3.7 [32] and Delano Scientific’s PYMOL (http://pymol.
sourceforge.net/).
Statistical analysis
The results are presented as mean 6 SD. The statistical
significance of the experimental results was determined by Student’s
t-test. Values of p,0.05 were considered statistically significant.
Prism version 5.0 was used for all statistics.
Results
Antibacterial activity of B. mattogrosensis crude venom
Based on the perspective of find novel antimicrobial agents in
snake venoms the antibacterial activity of B. mattogrosensis crude
venom (CVBm) against bacteria pathogenic to humans was
evaluated. Our results demonstrated that B. mattogrosensis crude
venom was active against Gram-positive and -negative bacteria
(Table 1). B. mattogrosensis venom showed activity against Gram-
negative bacteria, being most active against K. pneumoniae with
MIC of 64 mg.mL
21, followed by deleterious activity obtained
against E. coli and S. typhimurium with MICs of 128 mg.mL
21.O n
the other hand, venom was also evaluated toward P. mirabilis, P.
aeruginosa and all other Gram-positive bacteria, showing lower
antimicrobial effectiveness with MICs greater than 256 mg.mL
21.
Purification of antibacterial protein from crude venom of
the snake B. mattogrosensis
Aiming to identify the antibacterial component from CVBm,
crude venom was applied onto a gel filtration chromatograph
(Figure 1A). Protein elution was monitored by measuring the
absorbance at 280 nm, yielding three major protein peaks.
Antibacterial activity was further assayed by using all peak
fractions (Table 1). The fractions that showed highest antibacterial
activity were fractions F-44, F-51 and F-68 (Table 1). These
fractions were able to inhibit Gram-positive and -negative
bacteria, with fraction F51 being highly effective against pathogens
with lower MICs (8 mg.mL
21) against K. pneumoniae and P.
aeruginosa (Table 1). These data are similar to previous results
found for CVBm (Table 1), which showed higher activity against
Gram-negative bacteria. Three fractions from gel filtration
chromatography with antibacterial activities (F-44, F-51 and F-
68) had their apparent molecular masses evaluated by SDS-
PAGE. Fractions F-44, F-51 and F-68 showed a main protein with
,60 kDa and several contaminants (Figure 1B).
Fraction 51 that showed highest antibacterial activity was
further applied into a reversed-phase HPLC chromatograph,
generating 17 fractions (Figure 1C). Fraction 7 (BmLAO) showed
higher antibacterial activity in comparison to all others evaluated
(Table 1). This fraction was capable of efficiently inhibiting the
development of K. pneumoniae and P. mirabilis with MICs of
(2 mg.mL
21). Moreover, as expected, fraction 7 was more active
against Gram-negative bacteria and it was possible to acquire
fragments for de novo sequencing. The fragments were fragmented
by LIFT on MALDI ToF/ToF and de novo sequencing (Figure S1).
The partial sequence of the enzyme isolated from the venom of B.
mattogrosensis presented 100% of identity with LAO previously
isolated from B. pauloensis venom [3].
After de novo sequencing, the fragments obtained and selected for
synthesis were denominated BmLAO-f1 (IKFEPPLPPKKAH-NH2),
BmLAO-f2 (KKFWEDDG-NH2)a n dBmLAO-f3 (IYYPPNHNFP-
NH2), respectively, in accordance with alignment (Figure 2). These
three peptide fragments were chemically synthesized and further
evaluated toward Gram-positive and -negative bacteria. Peptide
fragments BmL A O - f 1 ,f 2a n df 3s h o w e dM I Cv a l u e sf r o m2 0t o4 5 ,
125 to 250 and 110 to 220 mM for Gram-positive and –negative
bacteria described in this work, and BmLAO-f1 revealed the highest
activity (Table 1). In summary, natural protein BmLAO showed
Antimicrobial LAO from Pitviper Venom
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peptides (BmLAO-f1, BmLAO-f2 and BmLAO-f3). Fragments are
also interesting as biotechnological products due to the low cost
incurred by their small size for synthesis facilities.
Evaluation of LAO activity
Comparing the molecular mass of protein found in BmLAO with
the literature, there is strong evidence that the protein found in this
fraction was an L-amino oxidase (LAO). LAOs are able to convert
L-amino acids into keto acids, ammonia and H2O2. LAO activity
was determined by monitoring H2O2 production [33]. Table 2
shows that BmLAO presented clear enzymatic activity in the
presence of different amino acid substrates, with the highest activity
observed in the presence of L-leucine (34062.5) followed by His
(32268.2), a classic substrate of LAO [33]. Otherwise, threonines
and cysteines were unaffected by the LAO reported here.
Evaluation of cytotoxicity
The in vitro cytotoxicity of F-44, F-51, F-68, BmLAO, BmLAO-
f1, BmLAO-f2 and BmLAO-f3 was studied with RAW264.7 and
human erythrocytes (Table 3). The in vitro cytotoxicity studies
confirmed that BmLAO, BmLAO-f1, BmLAO-f2 and BmLAO-f3
showed less than 25% haemolysis and over 78% of cell viability
even at higher concentrations.
Structural analyses of fragment peptides
L-amino acid oxidase (LAO, EC 1.4.3.2) is an enzyme with two
subunits. Each subunit consists of 15 a-helices and 22 b-strands that
fold into three well-defined domains (Figure 3). These subunits are
structurally composed of three domains, a FAD-binding domain, a
substrate-binding domain and a helical domain. In this report, the
structure of Vipera ammodytes ammodytes LAO, previously determined
by X-ray crystallography (pdb 3kve) with resolution of 2.57 A ˚ [11],
was used as a template for construction of three-dimensional model
fragments. All three fragments showed complete identity (100%)
with the template. The enzyme also presented theoretical positive
chargeof+3.5inaccordancewith the ProteinCalculatorv3.3 server
(http://www.scripps.edu/,cdputnam/protcalc.html). The frag-
ment model presented random coil conformations (BmLAO-f1
and BmLAO-f3) and also a-helical tendencies (BmLAO-f2) f
(Figure 4). The validation of structure fragments was performed
by Ramachandran plot, showing that 100% of the amino acid
residues from all models are in physically acceptable regions in
relation to torsion angles phi and psi. The values of root mean
squaredeviation(RMSD)forpeptidefragmentswere 1.79,1.64 and
1.80 A ˚, indicating that the model presented accepted modification
and is in accordance with Ramachandran plot. This modification
occurs due to side chain liberty in space.
Initially, BmLAO-f1 presented a coil conformation with a
hydrophilic and cationic C-terminal composed of Lys
10,L y s
11 and
His
13.F u r t h e r m o r e ,a na-helical region with net charge +3 was also
observed, in accordance with APD prediction describing the structure.
The central region is proline-rich with some distributed hydrophobic
residues (Phe
3,L e u
7) that confer 30% hydrophobic ratio, which
probably favours the interaction with phospholipid cell membrane
(Figure 4A). In addition, BmLAO-f2 structurally presented a
hydrophilic helical conformation composed of Lys
1,L y s
2,G l u
5,
Asp
6and Asp
7that confer a negative charge (21) and the formation of
a dipole helix. One feature that might assist interaction with the
membrane is the presence of Phe
3 and Trp
4 residues (25%
hydrophobic ratio) (Figure 4B). The presence of tryptophan located
in the peptide centre might favour a better anchorage by hydrophobic
interaction with lipid cell membranes. Finally, BmLAO-f3 structurally
presented coil conformation due to the presence of two proline
residues (Pro
4 and Pro
5) that may make helix formation difficult. The
peptide also presents a hydrophobic residue ratio of 22% with an Ile
1
and Phe
8 at the N- and C-termini, respectively, which could also
contribute to peptide-lipid interaction (Figure 4C).
Discussion
Currently, HAIs are a major cause of mortality and morbidity
among human populations, with wide distribution in many
developed and developing countries [1]. Given this fact,
fundamental research that aims to develop novel strategies for
Table 1. Antibacterial activity of CVBm, fractions obtained by gel filtration, HPLC chromatography and fragments obtained after
de novo sequencing.
Microorganisms MIC* (mg.mL
21)
CVBm Fractions Fragment (mM/mg.mL
21)
F-44 F-51 F-68 BmLAO BmLAO-f1 BmLAO-f2 BmLAO-f3
Gram-positive
Bacillus subtilis (ATCC 6633) 512 64 32 128 32 43/64 250/256 220/256
Enterococcus faecalis (ATCC 12953) 512 64 32 128 32 43/64 125/128 110/128
Staphylococcus aureus (ATCC29213) 256 128 32 128 32 43/64 250/256 220/256
Streptococcus pyogenes (ATCC19615) 256 64 32 64 8 43/64 125/128 110/128
Gram-negative
Escherichia coli (ATCC8739) 128 64 16 64 4 22/32 250/256 220/256
Klebsiella pneumoniae (ATCC13885) 64 32 8 64 2 22/32 125/128 110/128
Proteus mirabilis (ATCC25933) 256 32 16 38 2 43/64 125/128 110/128
Pseudomonas aeruginosa (ATCC15442) 256 32 8 64 8 22/32 250/256 220/256
Salmonella typhimurium (ATCC14028) 128 64 16 64 8 43/64 250/128 220/256
*MIC (Minimum Inhibitory Concentration) is defined as the lowest concentration that inhibited 100% of bacterial growth.
Inhibition by each sample was determined after 12 h incubation. CVBm: B. mattogrosensis crude venom; BmLAO: B. mattogrosensis L-amino acid oxidase; BmLAO-f1,
-f2 and -f3: B. mattogrosensis L-amino acid oxidase fragments 1, 2 and 3.
doi:10.1371/journal.pone.0033639.t001
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molecules obtained from natural sources, with direct action on
specific cases of these infections. Pitviper venoms contain
components with known pharmacological effects, including
hypertensive activity, inhibition of platelet aggregation, and
anticoagulant, antitumor and antimicrobial activities [3].
In this work, the antimicrobial activity of B. mattogrosensis crude
venom was evaluated, exhibiting promising antibacterial activity
against Gram-positive and -negative bacteria (Table 1). Similar
results were presented by San and colleagues [34], observing that
venoms from Calloselasma rhodostoma and Ophiophagus hannah snakes
show the ability to inhibit S. aureus development. Other crude
Figure 1. Purification process of antibacterial protein from Bothrops mattogrosensis venom. (A) Sephacryl S-100 chromatography profile.
Thirty milligrams of CVBm (crude venom of B. mattogrosensis) was applied on to the column at a flow rate of 1.8 mL.min
21. The protein content was
monitored by measuring the absorbance at 280 nm. (B) SDS-PAGE of CVBm (C) and gel filtration fractions (44, 51 and 68) with antibacterial activities.
M corresponds to molecular mass markers. (C) Chromatographic profile of Fraction (51) applied onto a RP-HPLC C-18. Diagonal line represents a linear
acetonitrile gradient (0–100%). Proteins were eluted at a flow rate of 2.5 mL.min
21.
doi:10.1371/journal.pone.0033639.g001
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Bothrops atrox, Lachesis muta and Bothrops alternatus were also effective
against S. aureus, S. epidermidis, Enterococcus faecalis and E. coli [35].
In the present work, a LAO was identified as an important
component of CVBm antimicrobial activity, also exhibiting
antibacterial activity against Gram-positive and -negative bacteria
(Table 1). LAO is a multifunctional enzyme that plays an
important role in host innate immunity [33,36], being commonly
found in many organisms including bacteria [37], fungi [38], green
algae [39], molluscs [40], fish [41], birds [42], reptiles [43] and
mammals [44]. In recent years, LAOs with antibacterial activity
have been reported from various venoms [6,7,45]. LAO enzyme is
able to catalyze the oxidation of a large number of amino acids,
and this reaction takes place in two key steps. First, the enzyme is
reduced by amino acids substrates and then there is a further re-
oxidation of the enzyme by molecular oxygen [46]. Data reported
indicate that oxidation products of the reaction are an amino acid
and also H2O2. The production of the latter seems to be essentially
involved in antibacterial activity. Yang et al. [13], working with a
LAO from fungal sources (Trichoderma harzianum), showed that
increased exogenous H2O2 produced by enzymes and reactive
oxidative species accumulated in target bacteria may trigger forms
of cell damage, including lipid peroxidation and DNA strand
breakage, resulting in bacterial development inhibition. Results
indicate that the processes of bacterial interaction, membrane
permeabilization and H2O2 production are directly involved in the
mechanism responsible for the antibacterial activity of LAO.
Other biological effects have been related to the production of
H2O2 by LAO. The L-amino oxidase synthesized by Bothrops
leucurus showed the ability to inhibit platelet aggregation as well as
exhibiting an in vitro lethal effect against Leishmania sp.,
promastigotes. Moreover, the cytotoxicity of this same compound
was observed against stomach cancer MKN-45, adeno carcinoma
HUTU, colorectal RKO and human fibroblast LL-24 cell lines
[8]. In summary, the enzyme released sufficient H2O2 in culture
medium to induce cellular apoptosis in a dose- and time-
dependent manner, corroborating data here reported.
Furthermore, the enzyme sequence here obtained presented
100% of identity with LAO previously isolated from B. pauloensis
venom [3]. In spite of full identity, it is not possible to conclude for
certain that these two enzymes are identical, since a complete
sequence was not performed. Moreover, the fragments obtained
from de novo sequencing were observed in the region that includes
323–420 amino acid residues. In the literature it has been reported
that the substrate-binding domain is made up of residues 5–25,
73–129, 233–236 and 323–420 [47]. Recently, Sun and
collaborators described a LAO, named Akbu-LAO, which was
also characterized by HPLC-ESI-MS/MS showing ten de novo
sequenced peptides [12]. These peptides presented 100% of
Figure 2. Multiple alignments of protein fragments determined by MALDI ToF/ToF of BmLAO against a wide diversity of L-amino
oxidases from different snake species. The black coils represent a-helices and black arrows b-sheets. Numbers represent the positions of amino
acid residues obtained from Gloydius halys (pdb 1tdk) L-amino-oxidase.
doi:10.1371/journal.pone.0033639.g002
Table 2. Enzyme activity of B. mattogrosensis L-amino acid
oxidase (Bm-LAO).
Aminoacid Specific activity (U.mg
21)
Leu 34062.5
*
His 32268.2
**
Phe 24466.4
Thr 763.2
Cys 564.0
Values are expressed mean 6 S.D. for three independent experiments.
*p,0.05, compared to negative control (PBS buffer, pH 7.4);
**p,0.01 compared to negative control.
doi:10.1371/journal.pone.0033639.t002
Table 3. Cytotoxic activities of Bm-LAO, fractions 7, 44, 51, 68
the fragments 1, 2 and 3 against RAW264.7 cells and human
erythrocytes.
Sample Cytotoxicity
MTT assay Hemolysis assay
% of control
CVBm 20.062.7
* 18.062.5
*
Bm-LAO 18.163.7
* 12.565.3
*
Fraction 7 22.462.5
* 17.364.1
*
Fraction 44 13.664.5
* 6.463.8
*
Fraction 51 11.262.1
* 16.562.7
*
Fraction 68 20.563.5
* 22.962.9
*
BmLAO-f1 21.063.5
* 13.7563.6
*
BmLAO-f2 13.664.5
* 11.3262.9
*
BmLAO-f3 11.262.1
* 9.8763.1
*
Samples (512 mg.mL
21) were incubated with the cells for 24 h. Cell viability was
assessed by MTT assay and hemolytic assay. Values are expressed mean 6 S.D.
for three independent experiments.
*p,0.05, compared to negative control (PBS buffer, pH 7.4). CVBm: B.
mattogrosensis crude venom; Bm-LAO: B. mattogrosensis L-amino acid oxidase.
doi:10.1371/journal.pone.0033639.t003
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showed that the substrate-binding domain is very highly conserved
in the LAOs of various snake species. The sequences were in
alignment with other LAOs and might indicate that this region is
extremely conserved in this protein class.
In recent years, several fragments from larger proteins with
antimicrobial properties have been evaluated showing major or
similar antimicrobial activities in comparison to complete
sequence [48–50]. Thennarasu and Nagaraj (1996) [48] examined
the antimicrobial and hemolytic activities of the 18-residue
segment pardaxin N-terminal. Despite presenting only antimicro-
bial activity, complete pardaxin shows both antimicrobial and
hemolytic activities, indicating that a reductional approach
improved bacterial selectivity. Sigurdardottir and colleagues [49]
evaluated the activity of three peptides derived from human
cathelicidin antimicrobial peptide LL-37. The activities of N- and
C-terminal fragments were significant lower than LL-37. Howev-
er, GKE, a peptide with a-helical propensity, showed higher
activity against bacteria and fungi and was less haemolytic than
LL-37. More recently, Papareddy et al. [50] described several
fragments of human thrombin with antimicrobial activity
generated by proteolysis. These fragments show similar activities
to LL-37, while the complete human thrombin shows no
antimicrobial activity.
This work is the first report of fragments of LAO with
antimicrobial activity. The fragments here reported showed lower
activities in comparison to complete BmLAO. Nonetheless, they
could be more useful than BmLAO, since they have a lower amino
acid length. Approaches targeting smaller peptides are needed,
since they are easier to synthesize, present fewer side effects (such
as allergy) and could be less haemolytic [51].
The fragments here reported have unusual properties for
antimicrobial peptides in spite of some characteristics that are
commonly shared with general AMPs, such as hydrophobicity and
amphipathicity. BmLAO-f1 has an unusual proline motif com-
posed of PPLPP between the amino acid 5- and 9-position
residues, comparing the BmLAO-f1 to AMPs deposited on APD.
This motif is similar to that observed on the PR-bombesin proline-
rich peptide, extracted from the toad Bombina maxima [52] and
which shows in vitro activity against Gram-positive, -negative and
fungi [53]. Indeed, the sequences are similar, showing 41% of
identity. Additionally, BmLAO-f1 shows a net charge of +3 and is
composed of 30% of hydrophobic residues, like PR-bombesin,
which shows a net charge of +3 and is composed of 31%
hydrophobic residues. On the other hand, BmLAO-f1 is not as
active as PR-bombesin, probably due to a change in proline motif;
PR-bombesin has an arginine residue instead of a leucine in
proline motif, which increases the affinity to negatively charged
membranes. Besides, an interesting finding is observed when the
sequence of PR-bombesin is compared to the mirrored sequence
of BmLAO-f1, because the proline motif can be expanded to
KKPPXPPX[WF]X[IV], where X can be any of 20 natural
amino acids. The lysine residues are probably responsible for
bacterial membrane attraction and the proline residues are
involved in hydrophobic interactions with the lipid bilayer, as
observed for PR-bombesin. Due to proline content, it probably
assumes a random coil conformation, like PR-bombesin [53]. Due
to the lack of folding, the motif probably works in two orientations,
and the great difference between PR-bombesin and BmLAO-f1 is
the arginine residue in the middle of the proline residues, present
only in PR-bombesin.
BmLAO-f2 is an anionic peptide with charge 21 and moderate
ratio hydrophobic content 25%. The peptide presents two lysines
(Lys
1 and Lys
2) and one tryptophan (Trp
4). These residues might
be important in the interaction with bacterial cell membranes for
attraction and anchorage. A similar peptide, named temporin 1Ja,
shows a similar net charge (21) and was isolated from Rana
japonica. This peptide presented weak activity with MIC values for
Gram-negative and - positive bacteria above 100 mM [54], while
the peptide produced here was more potent.
Figure 3. Three-dimensional structure of L-amino-oxidase from Vipera ammodytes ammodytes (pdb 3kve) and theoretical models of
peptide derivatives (A) BmLAO-f1, (B) BmLAO-f2 and (C) BmLAO-f3. Blue and red regions correspond to the cationic and anionic areas,
respectively. The structure was visualized using PyMOL (http://pymol.sourceforge.net/).
doi:10.1371/journal.pone.0033639.g003
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BmLAO-f1, (B) BmLAO-f2 and (C) BmLAO-f3. Exposed residues probably involved in membrane interaction are labelled and side chains are also
represented.
doi:10.1371/journal.pone.0033639.g004
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Nonetheless, BmLAO-f3 is not as hydrophilic and cationic as
BmLAO-f1, which probably contributes to its lower activity when
compared to BmLAO-f1. BmLAO-f3 has a net charge of +1,
reducing its membrane attraction, when compared to BmLAO-f1
(net charge of +3). A peptide’s net charge is a well-known property
that favours interaction with bacterial membranes through
electrostatic interaction [55,56]. However, its hydrophobic
residues compensate for the charge through hydrophobic
interactions, mainly the two tyrosines at N-terminal and the
phenylalanine at C-terminal. A similar result was reported by
Mandal et al. [57] in a work which evidenced two peptides
(CnAMP-2 and CnAMP-3) with antimicrobial activity from Cocos
nucifera presenting hydrophobic residues such as tyrosine and
phenylalanine [57]. This kind of residue is extremely common in
antimicrobial peptides that are well characterized in the literature,
such as magainin, fowlicidin, mastoparan and LL-37 [58–61].
Furthermore, some peptides showed higher activity toward Gram-
negative bacteria than towards Gram-positive ones. In this case, as
supported by our data with BmLAO-f1, peptides presented
exposed cationic amino acid residues that could play a key role
in the interaction with bacterial cell membranes. Several AMPs
that target bacteria are cationic and may interact with the anionic
lipid components which are exposed on the bacterial membrane.
Nevertheless, bacteria diverge extensively in the nature of the
major cell membrane lipid components. Those bacteria with
anionic and/or zwitterionic or neutral lipids can be induced to
form domains in the presence of cationic AMPs [62]. This
separation of anionic and zwitterionic lipids into domains can
result in bacterial cell death. Such agents are normally more lethal
to Gram-negative bacteria, as observed by BmLAO-f1, than to
Gram-positive ones, emphasizing the importance of the bacterial
membranes’ lipid composition in determining susceptibility to
antimicrobial agents. Moreover, in vitro comparisons between
MICs of complete LAO and three fragments suggest that
specificity could be related to exposed charges and hydrophobicity.
These data demonstrate that other regions with different
physicochemical properties could be also attractive for interaction
with bacterial cell membranes.
Conclusions
This is the first report of fragments of the LAO protein from
Bothropoides mattogrosensis against pathogens such as B. subtilis, E.
faecalis, S. aureus, S. pyogenes, E. coli, K. pneumonia, P. mirabilis, P.
aeruginosa and S. typhimurium. The activity of these fragments can be
improved by modifying the peptide by substitution or deletion of
residues. Thus the fragments reported here may be promising
candidates in the rational design of new antibiotics that can act
against resistant microorganisms.
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